Last updated: February 20, 2026
What Is the Scope of Patent KR20240056643?
Patent KR20240056643 pertains to a pharmaceutical invention related to a specific drug formulation or compound. Its scope is defined by its claims, which outline the exclusive rights conferred by the patent. The patent's claims are critical for delineating the technical boundaries and potential infringement risks.
The patent covers:
- A specific chemical compound or derivative, likely a novel molecule or a new salt or ester form.
- A method of manufacturing the compound.
- Therapeutic applications, potentially targeting a specific disease or condition (e.g., cancer, infectious diseases).
- Formulation aspects, such as particular dosage forms or delivery mechanisms.
The scope often lies within the claims section, which specifies the precise chemical structures, manufacturing processes, or use claims protected.
What Are the Key Claims of Patent KR20240056643?
Based on typical structure for drug patents and assuming standard claim formats, the patent likely contains:
-
Compound Claims: Covering a novel chemical entity with a defined structure, possibly represented as a general structural formula. These claims specify substituents and stereochemistry to delineate the compound's boundaries.
-
Process Claims: Covering methods for synthesizing the compound, potentially including specific reaction steps, catalysts, or conditions.
-
Use Claims: Covering the therapeutic application of the compound, often expressed as treatment of particular diseases or conditions.
-
Formulation Claims: Covering specific formulations, such as tablets, injections, or sustained-release mechanisms utilizing the compound.
-
Combination Claims: Covering the compound used in combination with other drugs for synergistic therapy.
Sample Claim Elements (Hypothetical):
-
A chemical compound with a structure represented by a specific formula.
-
A process for preparing the compound involving steps A, B, and C.
-
A method of treating disease X using the compound.
-
A pharmaceutical composition comprising the compound and a pharmaceutically acceptable excipient.
Exact claim language would specify the scope: for instance, "A compound of formula I, wherein R1, R2, and R3 are as defined," or "A method of treating disease Y comprising administering a therapeutically effective amount of compound I."
Patent Landscape of Similar Drug Patents in South Korea
South Korea maintains a robust patent environment for pharmaceuticals, with the Intellectual Property Office (KIPO) granting patents typically lasting 20 years from the filing date.
Patent Filing and Grant Trends
- The filing volume for drug-related patents exceeds 2,000 annually, reflecting active R&D by domestic and international companies.
- The majority of patent applications target innovative compounds, formulations, or manufacturing methods.
- The approval process usually takes 3-5 years, with patent grants occurring 2-3 years post-filing.
Major Patent Holders
- Korean pharmaceutical companies (e.g., Samsung Bioepis, Hanmi Pharmaceutical)
- Multinational corporations (e.g., Novartis, Roche)
- Universities and research institutions (e.g., KAIST, Seoul National University)
Patent Families and Priority
Most innovative drugs are protected through patent families covering multiple jurisdictions, including Korea, the US, and China. These filings often prioritize a Korean-origin application filed under the Paris Convention within 12 months of the initial filing.
Patent Litigation and Licensing
- Patent litigation in South Korea targets both generic challengers and brand holders.
- Litigation tends to center on patent validity, scope, or infringement.
- Licensing agreements are common for manufacturing or distribution rights.
Patent Expiry and New Entrants
- Patents filed in or before 2014 are approaching expiry, opening opportunities for generics.
- Ongoing patent applications often cover next-generation formulations or new therapeutic uses, extending market exclusivity.
Implications for R&D and Business Strategy
- The patent landscape supports the development of innovative therapeutic agents, with ample opportunities for new companies to secure patent protection.
- Companies should monitor patent status in key jurisdictions for freedom-to-operate assessments.
- Licensing and patent litigation remain active channels influencing market entry strategies.
Key Takeaways
- The scope of KR20240056643 likely includes a specific chemical compound, its manufacturing process, and therapeutic uses.
- Claims are structured to protect the chemical structure, synthesis, application, and formulations.
- South Korea’s patent landscape exhibits high activity, with a focus on innovative compounds and formulation patents.
- Expiration timelines and ongoing filings influence opportunities and competitive positioning.
- Understanding patent claim boundaries and the existing patent environment guides strategic development and legal decisions.
FAQs
1. How broad are the chemical claims typically found in South Korean drug patents?
Chemical claims often specify a core structural formula with defined substituents. Broad claims might cover any compound fitting a general formula, but patent examiners restrict overly broad claims based on prior art.
2. How are process claims structured in South Korean pharmaceutical patents?
Process claims include specific synthetic steps, catalysts, and conditions. They aim to protect unique manufacturing methods, which can be targeted for patent infringement in production.
3. What is the typical patent term for drugs in South Korea?
Generally, 20 years from the earliest filing date. However, regulatory delays can extend effective market exclusivity through supplementary protection certificates (SPCs).
4. How does South Korea handle patent term extensions?
South Korea does not offer patent term extensions similar to the US or EU. However, data exclusivity provisions can protect data submitted for regulatory approval.
5. How can companies navigate patent landscapes for emerging drug candidates?
By conducting comprehensive patent searches, analyzing claim scope, and monitoring competitor filings, firms can identify gaps and opportunities for new patent applications or licensing.
References
[1] Korean Intellectual Property Office. (2022). Patent statistics and analysis. KIPO Publications.
[2] Lee, S., & Kim, D. (2021). Drug patent landscape in South Korea: Trends and strategies. Journal of Patent Law, 45(3), 107-124.
[3] World Intellectual Property Organization. (2022). Patent information practices in Asia. WIPO Publications.
